title: Hydroxyurea use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities.
authors.forename: Amanda M
authors.initials: AM
authors.lastname: Brandow
authors.forename: Julie A
authors.initials: JA
authors.lastname: Panepinto
mesh_terms: D000293:Adolescent; D000755:Anemia, Sickle Cell / Q000503:physiopathology / Q000523:psychology / Q000628:therapy; D000986:Antisickling Agents / Q000008:administration & dosage / Q000009:adverse effects; D001803:Blood Transfusion; D002648:Child; D016903:Drug Monitoring / Q000009:adverse effects*; D005239:Fear / Q000523:psychology; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage / Q000009:adverse effects; D008297:Male; D010349:Patient Compliance / Q000523:psychology; D020403:Patient Freedom of Choice Laws; D018570:Risk Assessment; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000986:Antisickling Agents; D006918:Hydroxyurea